Profound Medical Corp. (TSX:PRN)
Canada
· Delayed Price · Currency is CAD | Market Cap | 256.96M |
| Revenue (ttm) | 22.07M |
| Net Income (ttm) | -58.37M |
| Shares Out | 36.29M |
| EPS (ttm) | -1.93 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 47,159 |
| Average Volume | 17,934 |
| Open | 7.33 |
| Previous Close | 7.08 |
| Day's Range | 6.52 - 7.67 |
| 52-Week Range | 5.23 - 12.40 |
| Beta | 0.39 |
| RSI | 27.53 |
| Earnings Date | Mar 5, 2026 |
About Profound Medical
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company’s lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prosta... [Read more]
Financial Performance
In 2025, Profound Medical's revenue was $16.10 million, an increase of 50.73% compared to the previous year's $10.68 million. Losses were -$42.57 million, 53.0% more than in 2024.
Financial numbers in USD Financial StatementsNews
Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript
Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript
Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic ...
Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions Amidst Challenges
Q4 2025 Profound Medical Corp Earnings Call Transcript
Q4 2025 Profound Medical Corp Earnings Call Transcript
Profound Medical (PROF) Reports Q4 Revenue Below Expectations
Profound Medical (PROF) Reports Q4 Revenue Below Expectations
Profound Medical Q4 Earnings Assessment
Profound Medical (NASDAQ: PROF) reported its Q4 earnings results on Thursday, March 5, 2026 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Profound Medical missed es...
Profound Medical's Earnings: A Preview
Profound Medical (NASDAQ: PROF) is set to give its latest quarterly earnings report on Thursday, 2026-03-05. Here's what investors need to know before the announcement. Analysts estimate that Profoun...
Profound Medical Corp (PROF) Q4 2025 Earnings Report Preview: What To Expect
Profound Medical Corp (PROF) Q4 2025 Earnings Report Preview: What To Expect
Profound Medical (PROF) Celebrates Milestone in Poland with 500th Sonalleve Procedure
Profound Medical (PROF) Celebrates Milestone in Poland with 500th Sonalleve Procedure
Profound Medical (PROF) Introduces TULSA-PRO at Mount Sinai Hospital
Profound Medical (PROF) Introduces TULSA-PRO at Mount Sinai Hospital
Profound Medical (PROF) Surpasses Installation Goal with TULSA-PRO System
Profound Medical (PROF) Surpasses Installation Goal with TULSA-PRO System
Profound Medical (PROF) Sees Price Target Boost by Lake Street | PROF Stock News
Profound Medical (PROF) Sees Price Target Boost by Lake Street | PROF Stock News
Profound Medical (PROF) Marks Milestone at Johns Hopkins Hospital
Profound Medical (PROF) Marks Milestone at Johns Hopkins Hospital
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
Profound Medical marks major milestone as the hospital launches its state-of-the-art iMRI suite to expand access to advanced prostate care Profound Medical marks major milestone as the hospital launch...
Profound Medical Corp. Announces Closing of Private Placement
TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private pla...
Profound Medical increases private placement to $6.45M
Profound Medical Corp. Announces Upsize of Private Placement
TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has increased the size of its private placement pr...
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
Financing included participation by healthcare-dedicated investors alongside existing shareholders Financing included participation by healthcare-dedicated investors alongside existing shareholders
Profound Medical announces pricing of up to $40 million financing
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (Nasdaq:PROF; TSX:PRN) (“Profound” or the “Company”) today announced the sale of 5,142,857 common shares at a purchase price of $7.00 ...
Wall Street Analysts Think Profound Medical (PROF) Could Surge 82.37%: Read This Before Placing a Bet
The consensus price target hints at an 82.4% upside potential for Profound Medical (PROF). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...
Stanford Medicine's Dr. Pejman Ghanouni Receives RSNA's Cum Laude Award for CAPTAIN Perioperative Data Presentation
– CAPTAIN is the first randomized controlled trial ever comparing a new technology to the standard of care of robotic radical prostatectomy to successfully recruit to target – – CAPTAIN is the first r...
Profound Medical (PROF) Readies Launch of TULSA-AI Module for BPH Treatment
Profound Medical (PROF) Readies Launch of TULSA-AI Module for BPH Treatment
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
New BPH module and clinical data reinforce the TULSA Procedure™'s versatility in prostate disease, superior patient benefits, and potential for mainstream adoption New BPH module and clinical data rei...
Profound Medical (PROF) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
After losing some value lately, a hammer chart pattern has been formed for Profound Medical (PROF), indicating that the stock has found support. This, combined with an upward trend in earnings estimat...
Profound Medical (PROF) Just Flashed Golden Cross Signal: Do You Buy?
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?